Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Netherlands Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20063
20082
20102
20112
20121
20134
20142
20151
20161
20173
20182
20192
20201
20214
20224
20234
20244
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting11
Terminated5
Unknown status5
Active, not recruiting3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Medical Center Groningen5
UMC Utrecht4
European Organisation for Research and Treatment of Cancer - EORTC3
GlaxoSmithKline3
Maastricht Radiation Oncology3
The Netherlands Cancer Institute3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Daiichi Sankyo2
Leiden University Medical Center2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms50
Endometrial Neoplasms13
Ovarian Neoplasms9
Breast Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Urinary Bladder Neoplasms6
Lung Neoplasms5
Melanoma5
Neoplasms5
Carcinoma, Non-Small-Cell Lung4

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.